31.73
Precedente Chiudi:
$32.05
Aprire:
$32.29
Volume 24 ore:
673.10K
Relative Volume:
0.32
Capitalizzazione di mercato:
$4.00B
Reddito:
$1.12B
Utile/perdita netta:
$5.00M
Rapporto P/E:
3,173.00
EPS:
0.01
Flusso di cassa netto:
$-383.00M
1 W Prestazione:
+8.91%
1M Prestazione:
+39.58%
6M Prestazione:
+171.17%
1 anno Prestazione:
+241.14%
Indivior Plc Stock (INDV) Company Profile
Nome
Indivior Plc
Settore
Telefono
804-379-1090
Indirizzo
234 BATH ROAD, SLOUGH, BERKSHIRE
Confronta INDV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
INDV
Indivior Plc
|
31.73 | 4.00B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
120.08 | 53.10B | 9.40B | 2.65B | 2.22B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.66 | 42.93B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.41 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.35 | 28.22B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
454.21 | 19.27B | 3.08B | 1.24B | 1.07B | 25.61 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-06 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-22 | Ripresa | Jefferies | Buy |
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-07-23 | Iniziato | Piper Sandler | Overweight |
| 2024-04-03 | Iniziato | Craig Hallum | Buy |
| 2023-07-13 | Iniziato | Northland Capital | Outperform |
Mostra tutto
Indivior Plc Borsa (INDV) Ultime notizie
Is Indivior PLC (2IVB) stock attractive post correction2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
Published on: 2025-11-06 02:52:41 - newser.com
Can Indivior PLC stock reach $100 price targetTrade Ideas & Fast Moving Trade Plans - newser.com
Using Python tools to backtest Indivior PLC strategiesWeekly Trading Summary & Real-Time Volume Analysis - newser.com
Will Indivior PLC (2IVB) stock benefit from sector leadershipWeekly Trading Summary & Precise Swing Trade Entry Alerts - fcp.pa.gov.br
Will Indivior PLC stock deliver long term returnsEarnings Recap Summary & Proven Capital Preservation Methods - newser.com
Using RSI to spot recovery in Indivior PLCWeekly Stock Report & Risk Managed Investment Strategies - newser.com
How Indivior PLC stock trades during market volatilityWeekly Investment Report & AI Based Buy and Sell Signals - newser.com
Why analysts upgrade Indivior PLC stockEarnings Risk Report & Reliable Volume Spike Alerts - newser.com
Here's Why Indivior Stock Soared 15% Today - MSN
Applying chart zones and confluence areas to Indivior PLCJuly 2025 Spike Watch & Precise Swing Trade Entry Alerts - newser.com
Does Indivior PLC show high probability of reboundQuarterly Investment Review & Free Reliable Trade Execution Plans - newser.com
Can Indivior PLC stock beat market expectations this quarterJuly 2025 Sentiment & Free Reliable Trade Execution Plans - newser.com
Is Indivior PLC stock bottoming outQuarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com
Is Indivior PLC stock attractive for income investorsPortfolio Value Summary & Accurate Buy Signal Alerts - newser.com
Indivior (INDV) Is Up 25.9% After Strong Q3 Results and Raised Revenue Guidance Has The Bull Case Changed? - simplywall.st
INDV Crosses Above Average Analyst Target - Nasdaq
Real time scanner hits for Indivior PLC explainedPortfolio Profit Report & Expert Verified Movement Alerts - newser.com
EBIT per share of Indivior PLC – LS:A3DWFC - TradingView
Indivior to pursue a change in domicile from the U.K. to the U.S - MSN
One-Year Outcomes of Real-World RECOVERâ„¢ Study Published in Jo - GuruFocus
Leading vs lagging indicators on Indivior PLC performance2025 Institutional Moves & Long-Term Safe Investment Ideas - newser.com
Monthly buprenorphine treatment shows lower relapse rates in OUD patients - Investing.com
Intraday pattern recognizer results for Indivior PLC2025 Risk Factors & Free Fast Entry Momentum Trade Alerts - newser.com
Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine - PR Newswire
Indivior PLC’s Optimistic Earnings Call Highlights Growth - MSN
Will Indivior PLC stock benefit from infrastructure spending2025 Stock Rankings & Scalable Portfolio Growth Ideas - newser.com
Indivior PLC 2025 Q3ResultsEarnings Call Presentation (NASDAQ:INDV) 2025-11-01 - Seeking Alpha
Indivior outlines $150M OpEx savings and raises 2025 revenue guidance to $1.22B as SUBLOCADE growth accelerates - MSN
Indivior Plc Azioni (INDV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):